Skip to content
Disclosery

Balyasny Asset Management: DRUG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Balyasny Asset Management on DRUG, newest first. How the timeline and the estimate are built.

Balyasny Asset Management held 345,053 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 345,053 shares
    Change vs previous 13F +47,895 shares

    0.04% of the 13F portfolio, value $24,222,721.

    13F-HR 0001193125-26-351940 filed by Balyasny Asset Management L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 297,158 shares
    Change vs previous 13F +71,746 shares

    0.04% of the 13F portfolio, value $21,683,619.

    13F-HR 0001193125-26-226359 filed by Balyasny Asset Management L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 225,412 shares
    Change vs previous 13F +38,490 shares

    0.03% of the 13F portfolio, value $17,591,152.

    13F-HR 0001193125-26-054303 filed by Balyasny Asset Management L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 186,922 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $11,338,689.

    13F-HR 0001193125-25-282267 filed by Balyasny Asset Management L.P.
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).